A Study of Brenipatide (LY3537031) in Healthy Participants With Overweight or Obesity
A Study of Brenipatide (LY3537031) in Healthy Participants With Overweight or Obesity
Active, not recruiting · NCT07476118 · Registry updated 2026-07-16Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of Brenipatide (LY3537031) in Healthy Participants With Overweight or Obesity | Body Weight, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, nutritional disorder, obesity disorder, overnutrition | Active, not recruiting | Phase 1 | 2026-07-16 | NCT07476118 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Eli Lilly and Company | 370 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Fortrea Clinical Research Unit | Dallas | United States | 11 |
| Fortrea Clinical Research Unit - Daytona Beach | Daytona Beach | United States | 1 |
| Fortrea Clinical Research Unit Inc. - Madison | Madison | United States | 1 |